MYXOFIBROSARCOMA (MFS)
Clinical trials for MYXOFIBROSARCOMA (MFS) explained in plain language.
Never miss a new study
Get alerted when new MYXOFIBROSARCOMA (MFS) trials appear
Sign up with your email to follow new studies for MYXOFIBROSARCOMA (MFS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to cut radiation side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether giving a shorter course of radiation (3 weeks instead of longer) before surgery for soft tissue sarcoma can reduce long-term side effects. Each patient's treatment is personalized by choosing between proton or standard X-ray radiation. The study will enro…
Matched conditions: MYXOFIBROSARCOMA (MFS)
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called OKN4395, alone or with an immunotherapy (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses and see if the drug can shrink tumors. About 166…
Matched conditions: MYXOFIBROSARCOMA (MFS)
Phase: PHASE1 • Sponsor: Epkin • Aim: Disease control
Last updated May 13, 2026 16:03 UTC